| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5874894 | Journal of Stroke and Cerebrovascular Diseases | 2016 | 7 Pages |
Abstract
We found several predictors of CMB after initiation of antiplatelet drug therapy. The results help to identify patients who need closer monitoring and thorough control of risk factors in order to lower the risk of new CMB and associated complications.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Maria MD, Christian MD, Marcus MD, Anja MSc, Anja MD, Michael MD, Adam MD, Rita Werner, Hajo M. MD, Felix MD, Katja MD, Susanne MD,